Condition

Clinical trials for Chronic Kidney Disease

Active public studies that list Chronic Kidney Disease as a condition.

14active studies

10recruiting now

16countries represented

566largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

Atherosclerosis Cardiovascular Disease, Chronic Kidney DiseaseCondition

Orforglipron, PlaceboTreatment

Argentina566 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07241390See eligibility →

Recruiting nowNot applicable

The NTU JO-SMART Study

Knee Osteoarthristis, Diabetes (DM)Condition

NTU-JO Smart ProgramTreatment

Taiwan2 locations

National Taiwan University HospitalSponsor

Updated 2026-07-24 · NCT07317310See eligibility →

Recruiting nowPhase 4

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

Obesity, Chronic Kidney DiseaseCondition

Semaglutide, Virtual Weight Management CoachingTreatment

Canada1 locations

Western University, CanadaSponsor

Updated 2026-06-29 · NCT06396416See eligibility →

Recruiting nowPhase 2

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Chronic Kidney DiseaseCondition

NNC0519-0130, PlaceboTreatment

Argentina, Australia147 locations

Novo Nordisk A/SSponsor

Updated 2026-03-11 · NCT06717698See eligibility →

Recruiting nowPhase 2

UBT251 Injection Phase II Clinical Study (CKD)

Obesity &Amp; Overweight, Chronic Kidney DiseaseCondition

UBT251, UBT251Treatment

China1 locations

The United Bio-Technology (Hengqin) Co., Ltd.Sponsor

Updated 2025-11-25 · NCT07134335See eligibility →

Recruiting nowNot applicable

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

Metabolic Syndrome (MetS), Obesity & OverweightCondition

No interventionTreatment

Taiwan1 locations

Chang Gung Memorial HospitalSponsor

Updated 2025-11-25 · NCT07248371See eligibility →

Recruiting nowNot applicable

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

Coronary Artery Disease, Diabete MellitusCondition

Intervention not listedTreatment

China1 locations

Xijing HospitalSponsor

Updated 2025-09-18 · NCT07180368See eligibility →

Recruiting nowNot applicable

Cardiovascular Risk in Children With Chronic Conditions Study

Kidney Transplant, Familial HypercholesterolaemiaCondition

Intervention not listedTreatment

Hungary3 locations

Semmelweis UniversitySponsor

Updated 2025-08-08 · NCT07086989See eligibility →

Recruiting nowNot applicable

The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity

Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF)Condition

High protein and sodium mealTreatment

United States1 locations

University of Mississippi Medical CenterSponsor

Updated 2025-07-04 · NCT07052539See eligibility →

Recruiting nowNot applicable

Nanshan Elderly Cohort Study

Hypertension, Type 2 Diabetes MellitusCondition

Intervention not listedTreatment

China2 locations

Sun Yat-sen UniversitySponsor

Updated 2018-06-26 · NCT03569735See eligibility →

Opening soonPhase 4

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Chronic Kidney Disease, Type 2 DiabetesCondition

Finerenone, SemaglutideTreatment

United States1 locations

Baylor Research InstituteSponsor

Updated 2026-05-08 · NCT07547878See eligibility →

Opening soonPhase 2

Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease

Chronic Kidney DiseaseCondition

Survodutide (BI 456906), PlaceboTreatment

Locations pending0 locations

University Medical Center GroningenSponsor

Updated 2025-10-03 · NCT07206290See eligibility →

Invitation onlyNot applicable

Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

Diabetes Mellitus, Type 2, ObesityCondition

No treatment givenTreatment

South Korea1 locations

Novo Nordisk A/SSponsor

Updated 2026-06-29 · NCT07673822See eligibility →

Active, not recruitingPhase 2

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Overweight, ObesityCondition

Tirzepatide, PlaceboTreatment

Austria, Canada27 locations

Eli Lilly and CompanySponsor

Updated 2026-05-08 · NCT05536804See eligibility →

Related conditions

Obesity1,102 Obesity & Overweight220 Overweight205 Overweight and Obesity130 Type 2 Diabetes108 Hypertension107

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.